337 related articles for article (PubMed ID: 26413528)
1. MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report.
Petrillo M; Fusco R; Catalano O; Sansone M; Avallone A; Delrio P; Pecori B; Tatangelo F; Petrillo A
Biomed Res Int; 2015; 2015():514740. PubMed ID: 26413528
[TBL] [Abstract][Full Text] [Related]
2. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging.
Curvo-Semedo L; Lambregts DM; Maas M; Thywissen T; Mehsen RT; Lammering G; Beets GL; Caseiro-Alves F; Beets-Tan RG
Radiology; 2011 Sep; 260(3):734-43. PubMed ID: 21673229
[TBL] [Abstract][Full Text] [Related]
3. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy.
Park MJ; Kim SH; Lee SJ; Jang KM; Rhim H
Radiology; 2011 Sep; 260(3):771-80. PubMed ID: 21846762
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
5. Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer.
Intven M; Monninkhof EM; Reerink O; Philippens ME
Acta Oncol; 2015 Nov; 54(10):1729-36. PubMed ID: 25914930
[TBL] [Abstract][Full Text] [Related]
6. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
7. Assessment of response to chemoradiation therapy in rectal cancer using MR volumetry based on diffusion-weighted data sets: a preliminary report.
Carbone SF; Pirtoli L; Ricci V; Venezia D; Carfagno T; Lazzi S; Mourmouras V; Lorenzi B; Volterrani L
Radiol Med; 2012 Oct; 117(7):1112-24. PubMed ID: 22580810
[TBL] [Abstract][Full Text] [Related]
8. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy.
Kim SH; Lee JM; Hong SH; Kim GH; Lee JY; Han JK; Choi BI
Radiology; 2009 Oct; 253(1):116-25. PubMed ID: 19789256
[TBL] [Abstract][Full Text] [Related]
9. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.
Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ
Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761
[TBL] [Abstract][Full Text] [Related]
11. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
[TBL] [Abstract][Full Text] [Related]
12. Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT.
An YY; Kim SH; Kang BJ; Lee AW
J Korean Med Sci; 2015 Jun; 30(6):808-15. PubMed ID: 26028936
[TBL] [Abstract][Full Text] [Related]
13. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted imaging for evaluating lymph node eradication after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
Ryu KH; Kim SH; Yoon JH; Lee Y; Paik JH; Lim YJ; Lee KH
Acta Radiol; 2016 Feb; 57(2):133-41. PubMed ID: 25638800
[TBL] [Abstract][Full Text] [Related]
15. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
[TBL] [Abstract][Full Text] [Related]
16. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
[TBL] [Abstract][Full Text] [Related]
17. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
18. T staging of rectal cancer: accuracy of diffusion-weighted imaging compared with T2-weighted imaging on 3.0 tesla MRI.
Feng Q; Yan YQ; Zhu J; Xu JR
J Dig Dis; 2014 Apr; 15(4):188-94. PubMed ID: 24373561
[TBL] [Abstract][Full Text] [Related]
19. Best MRI predictors of complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
Sathyakumar K; Chandramohan A; Masih D; Jesudasan MR; Pulimood A; Eapen A
Br J Radiol; 2016; 89(1060):20150328. PubMed ID: 26828967
[TBL] [Abstract][Full Text] [Related]
20. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
